Strong growth outlook for Nordic Cancer Targeted Therapy Market as it expands at 10.9% CAGR through 2031
Targeted cancer therapy involves the use of specialized medications that selectively attack cancer cells by targeting specific molecular features, reducing damage to surrounding healthy cells.
The Nordic Cancer Targeted Therapy Market share is expected to reach US$ 3,117.4 million by 2031 from US$ 1,510.0 million in 2024. The market is estimated to record a CAGR of 10.9% from 2025 to...
0 Commenti
0 condivisioni